ARCHIVES

Somatuline Demonstrates 65.1 Percent Of Patients Progression-Free at 96 Weeks

This article is from The Cancer Letter archive.

Vol. 37 No. 7 | July 25, 2014

Download PDF Visit The Full Archive

Related Articles

Working Group Considering formal Cap On size of Cancer Center Support Grants

March 22, 1996

In Congress; GAO Says Some Yew Bark Lost In ’91, But Problems Are Being Corrected

September 11, 1992

In Brief: Urologist Appointed To NCAB; Stovall Named To US Pharmacopeia Oncology Advisory Panel

September 8, 1995

Cancer Death Rate Declines, Clark Tells Science Writers

April 8, 1977

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

L.A. County Nears Crucial Decision On Construction Funds

January 7, 1977